Synapse - Works

Results (2683)

Nomogram for predicting 5-year survival after primary surgery for epithelial ovarian cancer

Meeting Abstract

Chi, D.; Zivanovic, O.; Kolev, V.; Yu, C.; Levine, D. A.; Sonoda, Y.; Abu-Rustum, N. R.; Huh, J.; Barakat, R. R.; Kattan, M. W.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Association of peripheral blood absolute lymphocyte count (ALC) and clinical activity in patients (pts) with advanced melanoma treated with ipilimumab

Meeting Abstract

Berman, D. M.; Wolchok, J.; Weber, J.; Hamid, O.; O'Day, S.; Chasalow, S. D.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Employment status among low-income Caucasian and Latina breast cancer survivors

Meeting Abstract

Blinder, V. S.; Patil, S.; Diamant, A.; Thind, A.; Maly, R.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Pain and analgesic use in men with metastatic prostate cancer

Meeting Abstract

Basch, E. M.; Sit, L.; Fruscione, M.; Burke, L.; Kane, R.; George, D.; Carducci, M. A.; Matthew, P.; Beer, T. M.; Scher, H. I.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Phase IIb double-blind, randomized, placebo-controlled trials for the efficacy and safety of sorafenib in patients (pts) with metastatic or locally advanced breast cancer (BC): Review of the Trials to Investigate the Effects of Sorafenib in BC (TIES) program

Meeting Abstract

Baselga, J.; Gianni, L.; Gradishar, W. J.; Hudis, C.; Perez, E. A.; Piccart-Gebhart, M.; Schwartzberg, L. S.; Sledge, G.; Fleming, T. R.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Patient-reported outcomes in a randomized trial of everolimus with metastatic renal cell carcinoma patients

Meeting Abstract

Beaumont, J.; Cella, D.; Hutson, T.; Bracarda, S.; Grunwald, V.; Thompson, J.; Ravaud, A.; Urbanowitz, G.; Hollaender, N.; Motzer, R.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

The impact of obesity on adherence to the National Comprehensive Cancer Network (NCCN) guidelines recommending chemotherapy for patients with operable breast cancer

Meeting Abstract

Brewster, A. M.; Etzel, C.; Zhou, R.; Wong, Y.; Edge, S. B.; Blayney, D. W.; Wilson, J.; Hudis, C.; Weeks, J. C.; Theriault, R. L.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Phase I study of obatoclax mesylate (GX15-070MS), a Bcl-2 antagonist, plus topotecan in relapsed small cell lung carcinoma and other solid tumors

Meeting Abstract

Brown, A. B.; Rudin, C.; Rizvi, N.; Travis, W.; Takebe, N.; James, L. P.; Subzwari, S.; Tyson, L.; Markus, S.; Krug, L. M.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

A phase II evaluation of bevacizumab in the treatment of recurrent or persistent endometrial cancer: A Gynecologic Oncology Group (GOG) study

Meeting Abstract

Aghajanian, C.; Sill, M. W.; Darcy, K.; Greer, B.; McMeekin, D. S.; Rose, P. G.; Rotmensch, J.; Barnes, M. N.; Hanjani, P.; Leslie, K.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Elevated troponin and abnormalities of cardiac structure and function in AL cardiac amyloidosis

Meeting Abstract

Apridonidze, T.; Steingart, R.; Comenzo, R. L.; Hoffman, J. E.; Goldsmith, Y.; Liu, J.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save